-- Financing Receives A- Rating by the Kroll Bond Rating Agency --
NEW YORK, NY, February 1, 2016 – CRG, a healthcare-focused investment firm delivering pioneering growth capital solutions to the global healthcare market, announced today that it closed on a $167 million term loan securitization on behalf of Capital Royalty Partners II, L.P. and certain of its parallel investment vehicles (“CRG II”, or the “Fund”). The transaction was effective on January 15, 2016.
The securitization transaction – or Asset-Backed Securities (“ABS”) financing – is the first securitization completed by CRG and represents a significant milestone in CRG’s growth and development as a premier global healthcare investor. The financing consisted of an offering of ABS notes that were rated A- by the Kroll Bond Rating Agency. Goldman, Sachs & Co. acted as initial purchaser.
Mike Weinmann, CRG Managing Director, commented “We are gratified by the success of this landmark financing for a number of reasons. The transaction underscores CRG’s structuring capabilities and commitment to enhance returns to our Limited Partners. It positions CRG to offer more attractive financing solutions to secure and better serve our business partners over the long-term. It also enhances CRG’s reputation and cost of capital advantage as an investor competing in the global healthcare market.
“This ABS financing is unprecedented in the healthcare industry for both its structure and rating. CRG is the first among its peers to securitize a portfolio of long-term senior secured loans to healthcare companies while achieving a strong investment grade debt rating and an attractive cost of debt. Moreover, the success of this offering establishes a new investor base while streamlining the legal and structuring process for similar financings in subsequent funds,” Mr. Weinmann concluded.
Founded in 2003, CRG (previously known as Capital Royalty L.P.) is a healthcare-focused investment firm that delivers pioneering growth capital financing solutions to the global healthcare industry. With over $2 billion of assets under management across 40 healthcare investments, CRG provides growth capital to healthcare companies primarily through structured debt and senior secured loans. CRG works across the spectrum of healthcare products, technologies and services and targets investment sizes ranging between $20 million and $300 million. The firm partners with innovative, commercial-stage healthcare companies that address large, unmet medical needs who are seeking flexible financing solutions with a committed, value-add partner to achieve their growth objectives. CRG is headquartered in Houston, Texas with offices in Boulder, Colorado and New York, New York. Please visit us at www.crglp.com.
# # #
For further information, please contact CRG:
Mike Weinmann, Managing Director
This release does not constitute an offer to sell or buy any securities and may not be used or relied upon in connection with any offer or sale of securities. It does not constitute a solicitation of clients and may not be used or relied upon in connection with any solicitation of clients. The Fund had its final closing in 2013 and is not offering its securities for sale. This release is qualified in its entirety by reference to the offering materials of a specific investment opportunity. Neither the Fund nor CRG makes any representation or warranty, either express or implied, as to the accuracy, completeness or reliability of the information contained in this release. Statements in this release are made as of the date hereof unless stated otherwise herein, and the delivery of this release at any time shall not under any circumstances create an implication that the information contained herein is correct as of any time subsequent to such date. Neither the Fund nor CRG has any obligation to update the information contained in this release, including in the event that any such information becomes inaccurate. No person has been authorized to give any information or to make any representation concerning the matters in this release other than the information explicitly contained in this release, and, if given or made, such information or representation must not be relied upon as having been authorized. CRG and its affiliates reserve the right to modify any of the terms of any offering.
Certain information contained in this release constitutes “forward-looking statements (as defined in the U.S. private securities litigation reform act of 1995),” which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “seeks,” “plans,” “scheduled to,” “target,” “anticipate,” “project,” “estimate,” “intend,” “continue” or “believe” or the negatives thereof or other variations thereon or other comparable terminology. Due to various known or unknown risks and uncertainties, including those described in this release and the offering materials of a specific investment opportunity, actual events or results or the actual performance may differ materially from those reflected or contemplated in such forward-looking statements. As a result, you are cautioned not to place undue reliance on these forward-looking statements. No representation or warranty is made as to future performance or such forward-looking statements. The Fund and CRG expressly disclaim any and all liability relating to or resulting from the use of this release.